Triggering receptor expressed on myeloid cells-1 (TREM-1) as a therapeutic target in infectious and noninfectious disease: a critical review

References

• Janeway CA, Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20(1):197–216. doi:10.1146/annurev.immunol.20.083001.084359.
   PubMed Web of Science ®Google Scholar
• Gulati A, Kaur D, Krishna Prasad GVR, Mukhopadhaya A. PRR Function of Innate Immune Receptors in Recognition of Bacteria or Bacterial Ligands. Adv Exp Med Biol. 2018;1112:255–280. doi:10.1007/978-981-13-3065-0_18.
   PubMed Web of Science ®Google Scholar
• Allcock RJ, Barrow AD, Forbes S, Beck S, Trowsdale J. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. European J Immunol. 2003;33(2):567–577. doi:10.1002/immu.200310033.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164(10):4991–4995. doi:10.4049/jimmunol.164.10.4991.
   PubMed Web of Science ®Google Scholar
• Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 2017;177:81–95. doi:10.1016/j.pharmthera.2017.02.043.
   PubMed Web of Science ®Google Scholar
• Tammaro A, Kers J, Emal D, et al. Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation. Sci Rep. 2016;6(1):38275. doi:10.1038/srep38275.
   PubMedGoogle Scholar
• Arts RJ, Joosten LA, Dinarello CA, Kullberg BJ, van der Meer JW, Netea MG. TREM-1 interaction with the LPS/TLR4 receptor complex. European Cytokine Netw. 2011;22(1):11–14. doi:10.1684/ecn.2011.0274.
   PubMed Web of Science ®Google Scholar
• Thankam FG, Dilisio MF, Dougherty KA, Dietz NE, Agrawal DK. Triggering receptor expressed on myeloid cells and 5’adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target. Expert Rev Clin Immunol. 2016;12(11):1239–1249. doi:10.1080/1744666X.2016.1196138.
   PubMed Web of Science ®Google Scholar
• Weber B, Schuster S, Zysset D, et al. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog. 2014;10(1):e1003900. doi:10.1371/journal.ppat.1003900.
   PubMed Web of Science ®Google Scholar
• Kelker MS, Foss TR, Peti W, et al. Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 A. J Mol Biol. 2004;342(4):1237–1248. doi:10.1016/j.jmb.2004.07.089.
   PubMed Web of Science ®Google Scholar
• Radaev S, Kattah M, Rostro B, Colonna M, Sun PD. Crystal structure of the human myeloid cell activating receptor TREM-1. Structure. 2003;11(12):1527–1535. doi:10.1016/j.str.2003.11.001.
   PubMed Web of Science ®Google Scholar
• Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004a;350(5):451–458. doi:10.1056/NEJMoa031544.
   PubMed Web of Science ®Google Scholar
• Molloy EJ. Triggering Receptor Expressed on Myeloid Cells (TREM) family and the application of its antagonists. PRI. 2009;4(1):51–56. doi:10.2174/157489109787236292.
   Google Scholar
• Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett. 2008;116(2):111–116. doi:10.1016/j.imlet.2007.11.021.
   PubMed Web of Science ®Google Scholar
• Carrasco K, Boufenzer A, Jolly L, et al. TREM-1 multimerization is essential for its activation on monocytes and neutrophils. Cell Mol Immunol. 2019;16(5):460–472. doi:10.1038/s41423-018-0003-5.
   PubMed Web of Science ®Google Scholar
• Fu L, Han L, Xie C, et al. Identification of Extracellular Actin As a Ligand for Triggering Receptor Expressed on Myeloid Cells-1 Signaling. Front Immunol. 2017;8:917doi:10.3389/fimmu.2017.00917.
   PubMed Web of Science ®Google Scholar
• Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood. 2007;110(3):1029–1035. doi:10.1182/blood-2007-01-069195.
   PubMed Web of Science ®Google Scholar
• Read CB, Kuijper JL, Hjorth SA, et al. Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1. J Immunol. 2015;194(4):1417–1421. doi:10.4049/ji.mmunol.1402303.
   PubMed Web of Science ®Google Scholar
• El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett. 2007;111(1):36–44. doi:10.1016/j.imlet.2007.04.011.
   PubMed Web of Science ®Google Scholar
• Denning NL, Aziz M, Murao A, et al. Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis. JCI Insight. 2020;5(5):1–16. doi:10.1172/jci.insight.134172.
   Web of Science ®Google Scholar
• Cheng PC, Lin CN, Chen YJ, Chang FS, Tsaihong JC, Lee KM. Triggering receptor expressed on myeloid cells (TREM)-1 participates in Schistosoma mansoni inflammatory responses. Parasite Immunol. 2011;33(5):276–286. doi:10.1111/j.1365-3024.2011.01284.x.
   PubMed Web of Science ®Google Scholar
• Denner J, Eschricht M, Lauck M, et al. Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1. PLoS One. 2013;8(1):e55199. doi:10.1371/journal.pone.0055199.
   PubMed Web of Science ®Google Scholar
• Hyun J, McMahon RS, Lang AL, et al. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells. PLoS Pathog. 2019;15(7):e1007883. doi:10.1371/journal.ppat.1007883.
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Coberley SS, Olinger GG, et al. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses. JVI. 2006;80(14):7235–7244. doi:10.1128/JVI.00543-06.
   PubMed Web of Science ®Google Scholar
• Nochi H, Aoki N, Oikawa K, et al. Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. Am J Pathol. 2003;162(4):1191–1201. doi:10.1016/S0002-9440(10)63915-6.
   PubMed Web of Science ®Google Scholar
• Gibot S, Massin F. Soluble form of the triggering receptor expressed on myeloid cells 1: an anti-inflammatory mediator?. Intensive Care Med. 2006;32(2):185–187. doi:10.1007/s00134-005-0018-0.
   PubMed Web of Science ®Google Scholar
• Gomez-Pina V, et al. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol. 2007;179:4065–4073. doi:10.4049/jimmunol.179.6.4065.
   PubMed Web of Science ®Google Scholar
• Gingras MC, Lapillonne H, Margolin JF. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 2002;38(11):817–824. doi:10.1016/S0161-5890(02)00004-4.
   PubMed Web of Science ®Google Scholar
• Bosco MC, Pierobon D, Blengio F, et al. Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood. 2011;117(9):2625–2639. doi:10.1182/blood-2010-06-292136.
   PubMed Web of Science ®Google Scholar
• McMahon L, Schwartz K, Yilmaz O, Brown E, Ryan LK, Diamond G. Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect Immun. 2011;79(6):2250–2256. doi:10.1128/IAI.00099-11.
   PubMed Web of Science ®Google Scholar
• Li H, Hong F, Pan S, Lei L, Yan F. Silencing triggering receptors expressed on myeloid cells-1 impaired the inflammatory response to oxidized low-density lipoprotein in macrophages. Inflammation. 2016;39(1):199–208. doi:10.1007/s10753-015-0239-5.
   PubMed Web of Science ®Google Scholar
• Bleharski JR, Kiessler V, Buonsanti C, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol. 2003;170(7):3812–3818. doi:10.4049/jimmunol.170.7.3812.
   PubMed Web of Science ®Google Scholar
• Chen LC, Laskin JD, Gordon MK, Laskin DL. Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp Mol Pathol. 2008;84(2):145–155. doi:10.1016/j.yexmp.2007.11.004.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Kohsaka H, Kitasato H, Akahoshi T. Lipopolysaccharide-induced up-regulation of triggering receptor expressed on myeloid cells-1 expression on macrophages is regulated by endogenous prostaglandin E2. J Immunol. 2007;178(2):1144–1150. doi:10.4049/jimmunol.178.2.1144.
   PubMed Web of Science ®Google Scholar
• Gao S, Yi Y, Xia G, et al. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev. 2019;18(1):25–35. doi:10.1016/j.autrev.2018.07.008.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410(6832):1103–1107. doi:10.1038/35074114.
   PubMed Web of Science ®Google Scholar
• Hosoda H, Tamura H, Kida S, Nagaoka I. Transcriptional regulation of mouse TREM-1 gene in RAW264.7 macrophage-like cells. Life Sci. 2011;89(3-4):115–122. doi:10.1016/j.lfs.2011.05.007.
   PubMed Web of Science ®Google Scholar
• Zeng H, Ornatowska M, Joo MS, Sadikot RT. TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappaB and PU.1. Eur J Immunol. 2007;37(8):2300–2308. doi:10.1002/eji.200737270.
   PubMed Web of Science ®Google Scholar
• Tessarz AS, Weiler S, Zanzinger K, Angelisová P, Horejsí V, Cerwenka A. Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. J Immunol. 2007;178(4):1991–1999. doi:10.4049/jimmunol.178.4.1991.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Abram CL, Hundt M, Altman A, Lowell CA, Ley K. PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J Exp Med. 2008;205(10):2339–2347. doi:10.1084/jem.20072660.
   PubMed Web of Science ®Google Scholar
• McVicar DW, Taylor LS, Gosselin P, et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem. 1998;273(49):32934–32942. doi:10.1074/jbc.273.49.32934.
   PubMed Web of Science ®Google Scholar
• Radsak MP, Salih HR, Rammensee HG, Schild H. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. 2004;172(8):4956–4963. doi:10.4049/jimmunol.172.8.4956.
   PubMed Web of Science ®Google Scholar
• del Fresno C, Gómez-Piña V, Lores V, et al. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PLoS One. 2008;3(7):e2667. doi:10.1371/journal.pone.0002667.
   PubMed Web of Science ®Google Scholar
• Turkistany SA, DeKoter RP. The transcription factor PU.1 is a critical regulator of cellular communication in the immune system. Arch Immunol Ther Exp. 2011;59(6):431–440. doi:10.1007/s00005-011-0147-9.
   PubMed Web of Science ®Google Scholar
• Schenk M, Bouchon A, Birrer S, Colonna M, Mueller C. Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol. 2005;174(1):517–524. doi:10.4049/jimmunol.174.1.517.
   PubMed Web of Science ®Google Scholar
• Amatngalim GD, Nijnik A, Hiemstra PS, Hancock RE. Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds. Inflammation. 2011;34(5):412–425. doi:10.1007/s10753-010-9248-6.
   PubMed Web of Science ®Google Scholar
• Molad Y, Pokroy-Shapira E, Carmon V. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding. Innate Immun. 2013;19(6):623–630. doi:10.1177/1753425913476970.
   PubMed Web of Science ®Google Scholar
• Gibot S. Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis. Crit Care. 2005;9(5):485–489.
   PubMed Web of Science ®Google Scholar
• Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol. 2004;173(12):7131–7134. doi:10.4049/jimmunol.173.12.7131.
   PubMed Web of Science ®Google Scholar
• Ornatowska M, Azim AC, Wang X, et al. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol. 2007;293(6):L1377–1384. doi:10.1152/ajplung.00140.2007.
   PubMed Web of Science ®Google Scholar
• Zheng H, Heiderscheidt CA, Joo M, et al. MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands. Eur J Immunol. 2010;40(1):162–171. doi:10.1002/eji.200839156.
   PubMed Web of Science ®Google Scholar
• Lagler H, Sharif O, Haslinger I, et al. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol. 2009;183(3):2027–2036. doi:10.4049/jimmunol.0803862.
   PubMed Web of Science ®Google Scholar
• Wu M, Peng A, Sun M, et al. TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses. Infect Immun. 2011;79(7):2709–2716. doi:10.1128/IAI.00144-11.
   PubMed Web of Science ®Google Scholar
• Derive M, Bouazza Y, Sennoun N, et al. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol. 2012;188(11):5585–5592. doi:10.4049/jimmunol.1102674.
   PubMed Web of Science ®Google Scholar
• Chen G, Shaw MH, Kim YG, Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol Mech Dis. 2009;4(1):365–398. doi:10.1146/annurev.pathol.4.110807.092239.
   PubMed Web of Science ®Google Scholar
• Netea MG, Azam T, Ferwerda G, Girardin SE, Kim SH, Dinarello CA. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J Leukoc Biol. 2006;80(6):1454–1461. doi:10.1189/jlb.1205758.
   PubMed Web of Science ®Google Scholar
• Prufer S, et al. Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells. J Innate Immun. 2014;6:339–352. doi:10.1159/000355892.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhou Y, Li P, et al. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Sci Rep. 2016;6(1):39473. doi:10.1038/srep39473.
   PubMed Web of Science ®Google Scholar
• Jolly L, Carrasco K, Derive M, Lemarié J, Boufenzer A, Gibot S. Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock. Cardiovasc Res. 2018;114(6):907–918. doi:10.1093/cvr/cvy018.
   PubMed Web of Science ®Google Scholar
• Derive M, Boufenzer A, Bouazza Y, et al. Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs. Shock. 2013;39(2):176–182. doi:10.1097/SHK.0b013e31827bcdfb.
   PubMed Web of Science ®Google Scholar
• Derive M, Boufenzer A, Gibot S. Attenuation of responses to endotoxin by the triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate. Anesthesiology. 2014;120(4):935–942. doi:10.1097/ALN.0000000000000078.
   PubMed Web of Science ®Google Scholar
• Dubar M, Carrasco K, Gibot S, Bisson C. Effects of Porphyromonas gingivalis LPS and LR12 peptide on TREM-1 expression by monocytes. J Clin Periodontol. 2018;45(7):799–805. doi:10.1111/jcpe.12925.
   PubMed Web of Science ®Google Scholar
• Boufenzer A, Lemarié J, Simon T, et al. TREM-1 mediates inflammatory injury and cardiac remodeling following myocardial infarction. Circ Res. 2015;116(11):1772–1782. doi:10.1161/CIRCRESAHA.116.305628.
   PubMed Web of Science ®Google Scholar
• Lemarie J, et al. Pharmacological inhibition of the triggering receptor expressed on myeloid cells-1 limits reperfusion injury in a porcine model of myocardial infarction. ESC Heart Fail. 2015;2:90–99. doi:10.1002/ehf2.12029.
   PubMed Web of Science ®Google Scholar
• Joffre J, Potteaux S, Zeboudj L, et al. Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental. Atherosclerosis J Am Coll Cardiol. 2016;68(25):2776–2793. doi:10.1016/j.jacc.2016.10.015.
   PubMed Web of Science ®Google Scholar
• Shi R, Zhang J, Peng Z, et al. Expression level of 12-amino acid triggering receptor on myeloid cells-like transcript 1 derived peptide alleviates lipopolysaccharide-induced acute lung injury in mice. Int J Mol Med. 2018;41:2159–2168. doi:10.3892/ijmm.2018.3443.
   PubMed Web of Science ®Google Scholar
• Kokten T. TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice. J Crohns Colitis. 2018;12:230–244. doi:10.1093/ecco-jcc/jjx129.
   PubMed Web of Science ®Google Scholar
• Horst SA, Linnér A, Beineke A, et al. Prognostic value and therapeutic potential of TREM-1 in Streptococcus pyogenes- induced sepsis. J Innate Immun. 2013;5(6):581–590. doi:10.1159/000348283.
   PubMed Web of Science ®Google Scholar
• Shi X, Zhang Y, Wang H, Zeng S. Effect of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Blockade in Rats with Cecal Ligation and Puncture (CLP)-Induced Sepsis. Med Sci Monit. 2017;23:5049–5055. doi:10.12659/MSM.904386.
   PubMed Web of Science ®Google Scholar
• Qian L, Weng XW, Chen W, Sun CH, Wu J. TREM-1 as a potential therapeutic target in neonatal sepsis. Int J Clin Exp Med. 2014;7:1650–1658.
   PubMed Web of Science ®Google Scholar
• Bostanci N, Thurnheer T, Belibasakis GN. Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis. Mol Immunol. 2011;49(1-2):387–394. doi:10.1016/j.molimm.2011.09.012.
   PubMed Web of Science ®Google Scholar
• Bostanci N, Abe T, Belibasakis GN, Hajishengallis G. TREM-1 Is upregulated in experimental periodontitis, and its blockade inhibits IL-17A and RANKL expression and suppresses bone loss. J Clin Med. 2019;8:1–14. doi:10.3390/jcm8101579.
   Web of Science ®Google Scholar
• Gibot S, Alauzet C, Massin F, et al. Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis. 2006;194(7):975–983. doi:10.1086/506950.
   PubMed Web of Science ®Google Scholar
• Luo L, Zhou Q, Chen XJ, Qin SM, Ma WL, Shi HZ. Effects of the TREM-1 pathway modulation during empyema in rats. Chin. Med. J. 2010;123(12):1561–1565.
   PubMed Web of Science ®Google Scholar
• Feng C-W, Chen N-F, Sung C-S, et al. Therapeutic Effect of Modulating TREM-1 via Anti-inflammation and Autophagy in Parkinson's Disease. Front Neurosci. 2019;13:769doi:10.3389/fnins.2019.00769.
   PubMed Web of Science ®Google Scholar
• Sun XG, Duan H, Jing G, Wang G, Hou Y, Zhang M. Inhibition of TREM-1 attenuates early brain injury after subarachnoid hemorrhage via downregulation of p38MAPK/MMP-9 and preservation of ZO-1. Neuroscience. 2019;406:369–375. doi:10.1016/j.neuroscience.2019.03.032.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhang X, Liu Q, et al. Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. Cell Death Dis. 2019;10(8):555. doi:10.1038/s41419-019-1777-9.
   PubMedGoogle Scholar
• Du C, Peng L, Kou G, Wang P, Lu L, Li Y. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome. Dig Dis Sci. 2018;63(5):1182–1191. doi:10.1007/s10620-018-5002-y.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chai F, Lu G, et al. TREM-1 inhibition attenuates inflammation and tumor within the colon. Int Immunopharmacol. 2013;17(2):155–161. doi:10.1016/j.intimp.2013.06.009.
   PubMed Web of Science ®Google Scholar
• Dang S, Shen Y, Yin K, Zhang J. TREM-1 promotes pancreatitis-associated intestinal barrier dysfunction. Gastroenterol Res Pract. 2012;2012:1–8. doi:10.1155/2012/720865.
   Google Scholar
• Kamei K, Yasuda T, Ueda T, Qiang F, Takeyama Y, Shiozaki H. Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J Hepatobiliary Pancreat Sci. 2010;17(3):305–312. doi:10.1007/s00534-009-0191-6.
   PubMed Web of Science ®Google Scholar
• Wang F, Li C, Ding FH, et al. Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells. Atherosclerosis. 2017;267:10–18. doi:10.1016/j.atherosclerosis.2017.10.015.
   PubMed Web of Science ®Google Scholar
• Gibot S, Massin F, Alauzet C, et al. Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats. Shock. 2009;32(6):633–637. doi:10.1097/SHK.0b013e3181a53842.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Syed M, Panchal D, et al. TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine. Am J Physiol Lung Cell Mol Physiol. 2016;310(5):L426–438. doi:10.1152/ajplung.00195.2015.
   PubMed Web of Science ®Google Scholar
• Sigalov AB. A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock. Int Immunopharmacol. 2014;21(1):208–219. doi:10.1016/j.intimp.2014.05.001.
   PubMed Web of Science ®Google Scholar
• Shen ZT, Sigalov AB. Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis. J Cell Mol Med. 2017;21(10):2524–2534. doi:10.1111/jcmm.13173.
   PubMed Web of Science ®Google Scholar
• Tornai D, Furi I, Shen ZT, Sigalov AB, Coban S, Szabo G. Inhibition of triggering receptor expressed on myeloid cells 1 ameliorates inflammation and macrophage and neutrophil activation in alcoholic. Hepatol Commun. 2019;3(1):99–115. doi:10.1002/hep4.1269.
   PubMed Web of Science ®Google Scholar
• Gibot S, Jolly L, Lemarie J, Carrasco K, Derive M, Boufenzer A. Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation. Front Immunol. 2019;10:2314doi:10.3389/fimmu.2019.02314.
   PubMed Web of Science ®Google Scholar
• Hosoda H, Nakamura K, Hu Z, et al. Antimicrobial cathelicidin peptide LL37 induces NET formation and suppresses the inflammatory response in a mouse septic model. Mol Med Rep. 2017;16(4):5618–5626. doi:10.3892/mmr.2017.7267.
   PubMed Web of Science ®Google Scholar
• Sun G-Y, Guan C-X, Zhou Y, et al. Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injury. Regul Pept. 2011;167(1):56–64. doi:10.1016/j.regpep.2010.11.008.
   PubMedGoogle Scholar
• Mihailidou I, Pelekanou A, Pistiki A, et al. Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Front Public Health. 2013;1:50doi:10.3389/fpubh.2013.00050.
   PubMedGoogle Scholar
• Jeon K, Chung CR, Yang JH, Park CM, Suh GY. Predictors of response to corticosteroid treatment in patients with early acute respiratory distress syndrome: results of a pilot study. Yonsei Med J. 2015;56(1):287–291. doi:10.3349/ymj.2015.56.1.287.
   PubMed Web of Science ®Google Scholar
• Tong J, Liu ZC, Wang DX. Azithromycin acts as an immunomodulatory agent to suppress the expression of TREM-1 in Bacillus pyocyaneus-induced sepsis. Immunol Lett. 2011;138(2):137–143. doi:10.1016/j.imlet.2011.04.001.
   PubMed Web of Science ®Google Scholar
• Spyridaki A, Raftogiannis M, Antonopoulou A, et al. Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. Antimicrob Agents Chemother. 2012;56(7):3819–3825. doi:10.1128/AAC.05798-11.
   PubMed Web of Science ®Google Scholar
• Cui N, Wang H, Su LX, Zhang JH, Long Y, Liu DW. Role of triggering receptor expressed on myeloid cell-1 expression in mammalian target of rapamycin modulation of CD8(+) T-cell differentiation during the immune response to invasive pulmonary aspergillosis. Chin Med J (Engl). 2017;130:1211–1217. doi:10.4103/0366-6999.205850.
   PubMed Web of Science ®Google Scholar
• Huang W, Ling S, Jia X, et al. Tacrolimus (FK506) suppresses TREM-1 expression at an early but not at a late stage in a murine model of fungal keratitis. PLoS One. 2014;9(12):e114386. doi:10.1371/journal.pone.0114386.
   PubMed Web of Science ®Google Scholar
• Bostanci N, Belibasakis GN. Doxycycline inhibits TREM-1 induction by Porphyromonas gingivalis. FEMS Immunol Med Microbiol. 2012;66(1):37–44. doi:10.1111/j.1574-695X.2012.00982.x.
   PubMedGoogle Scholar
• Jiang WL, Chen XG, Zhu HB, Tian JW. Effect of cornuside on experimental sepsis. Planta Med. 2009;75(06):614–619. doi:10.1055/s-0029-1185383.
   PubMedGoogle Scholar
• Wang HM, Gao JH, Lu JL. Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12. Eur Rev Med Pharmacol Sci. 2018;22(15):4995–5003. doi:10.26355/eurrev_201808_15640.
   PubMed Web of Science ®Google Scholar
• Dai M, Chen Y, Mei X. Pravastatin sodium attenuated TREM-1-mediated inflammation in human peripheral blood mononuclear cells. Biochem Biophys Res Commun. 2019;508(1):225–229. doi:10.1016/j.bbrc.2018.11.098.
   PubMed Web of Science ®Google Scholar
• Kumar PS. From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease. J Physiol. 2017;595(2):465–476. doi:10.1113/JP272427.
   PubMed Web of Science ®Google Scholar
• Parent M, Clarot I, Gibot S, et al. One-week in vivo sustained release of a peptide formulated into in situ forming implants. Int J Pharm. 2017;521(1-2):357–360. doi:10.1016/j.ijpharm.2017.02.046.
   PubMedGoogle Scholar
• Cuvier V, Lorch U, Witte S, et al. A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition. Br J Clin Pharmacol. 2018;84(10):2270–2279. doi:10.1111/bcp.13668.
   PubMed Web of Science ®Google Scholar
• Gibot S, Kolopp-Sarda M-N, Béné M-C, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004b;200(11):1419–1426. doi:10.1084/jem.20040708.
   PubMed Web of Science ®Google Scholar
• Gibot S, Massin F, Alauzet C, et al. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med. 2008;36(2):504–510. doi:10.1097/01.CCM.0B013E318161FAF3.
   PubMed Web of Science ®Google Scholar
• Genua M, Rutella S, Correale C, Danese S. The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis. J Transl Med. 2014;12(1):293. doi:10.1186/s12967-014-0293-z.
   PubMed Web of Science ®Google Scholar
• Mashima R. Physiological roles of miR-155. Immunology. 2015;145(3):323–333. doi:10.1111/imm.12468.
   PubMed Web of Science ®Google Scholar
• Ho C-C, Liao W-Y, Wang C-Y, et al. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med. 2008;177(7):763–770. doi:10.1164/rccm.200704-641OC.
   PubMed Web of Science ®Google Scholar
• Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12(1):76. doi:10.1186/s13045-019-0760-3.
   PubMed Web of Science ®Google Scholar
• Fabisiak A, Murawska N, Fichna J. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. Pharmacol Rep. 2016;68(4):802–808. doi:10.1016/j.pharep.2016.03.015.
   PubMed Web of Science ®Google Scholar
• Xhindoli D, Pacor S, Benincasa M, Scocchi M, Gennaro R, Tossi A. The human cathelicidin LL-37–A pore-forming antibacterial peptide and host-cell modulator. Biochim Biophys Acta. 2016;1858(3):546–566. doi:10.1016/j.bbamem.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Mookherjee N, Brown KL, Bowdish DME, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol. 2006;176(4):2455–2464. doi:10.4049/jimmunol.176.4.2455.
   PubMed Web of Science ®Google Scholar
• Delgado M, Ganea D. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids. 2013;45(1):25–39. doi:10.1007/s00726-011-1184-8.
   PubMed Web of Science ®Google Scholar
• Ramamoorthy S, Cidlowski JA. Corticosteroids: Mechanisms of Action in Health and Disease Rheum Dis. Clin North Am. 2016;42(1):15–31. vii doi:10.1016/j.rdc.2015.08.002.
   Google Scholar
• Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270(5234):286–290. doi:10.1126/science.270.5234.286.
   PubMed Web of Science ®Google Scholar
• Hoyt JC, Robbins RA. Macrolide antibiotics and pulmonary inflammation. FEMS Microbiol Lett. 2001;205(1):1–7. doi:10.1111/j.1574-6968.2001.tb10917.x.
   PubMed Web of Science ®Google Scholar
• Wales D, Woodhead M. The anti-inflammatory effects of macrolides. Thorax. 1999;54(Supplement 2):S58–S62. doi:10.1136/thx.54.2008.S58.
   PubMedGoogle Scholar
• Bedi O, Dhawan V, Sharma PL, Kumar P. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn-Schmiedeberg's Arch Pharmacol. 2016;389(7):695–712. doi:10.1007/s00210-016-1252-4.
   Google Scholar
• Liu M-W, Liu R, Wu H-Y, et al. Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression. Exp Ther Med. 2017;14(2):917–930. doi:10.3892/etm.2017.4576.
   PubMed Web of Science ®Google Scholar